Company: ZCARW
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001213900-25-014437
Chunk: 536

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part II, Item 1
Chunk 536
---
 listing on The Nasdaq Capital Market (the “Equity Rule”), on or before March
31, 2025.

The Company is diligently working to satisfy the conditions set forth
in the Panel Decision Letter, including applying to transfer the listing of its securities to The Nasdaq Capital Market on or before February
19, 205. However, there can be no assurance that the Company will be successful in meeting such conditions or that the Company will be
able to maintain its listing on Nasdaq.

If we fail to comply with
the above condition and if Nasdaq thereafter delists our securities from trading on its exchange for failure to meet its listing standards,
and we are not able to list such securities on another national securities exchange, then our Common Stock could be quoted on an over-the-counter
market. If this were to occur, we and our stockholders could face significant material adverse consequences, including:

    ●
    a limited availability of market quotations for our securities;

    ●
    reduced liquidity for our securities;

    ●
    a determination that the Common Stock is a “penny stock,” which will require brokers trading the Common Stock to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for shares of Common Stock;

    ●
    a limited amount of news and analyst coverage; and

    ●
    a decreased ability for us to issue additional securities or obtain additional financing in the future.

If securities or industry analysts do not
publish or cease publishing research or reports about us, our business, or our market, or if they change their recommendations regarding
our securities adversely, the price and trading volume of our securities could decline.

The trading market for our
securities will be influenced by the research and reports that industry or securities analysts may publish about us, our business, markets,
revenue streams, and competitors. Securities and industry analysts do not currently, and may never, publish research on us. If no securities
or industry analysts commence coverage of us, our share price and trading volume would likely be negatively impacted. If any of the analysts
who may cover us adversely change their recommendation regarding our shares of Common Stock or provide relatively more favorable recommendations
with respect to competitors, the price of our shares of Common Stock would likely decline. If any analyst who may cover us were to cease
coverage of us or fail to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause
our share price or trading volume to decline